id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-E-0062-0006,FDA,FDA-2003-E-0062,Certificate Extending Patent Term from U.S. Patent and Trademark Office to Wyeth,Rule,Certificate Extending Patent Term,2007-04-23T04:00:00Z,2007,4,,,2025-10-29T19:41:10Z,,0,0,0900006480481b11
FDA-2003-E-0062-0005,FDA,FDA-2003-E-0062,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-09-07T04:00:00Z,2006,9,,,2025-10-29T19:38:31Z,,0,0,0900006480481b10
FDA-2003-E-0062-0004,FDA,FDA-2003-E-0062,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-06-19T04:00:00Z,2006,6,,,2025-10-29T19:34:17Z,,0,0,0900006480481b0f
FDA-2003-E-0062-0003,FDA,FDA-2003-E-0062,Determination of Regulatory Review Period for Purposes of Patent Extension; CYPHER,Notice,General Notice,2006-02-15T05:00:00Z,2006,2,2006-02-03T05:00:00Z,,2025-10-29T19:30:11Z,E6-1436,0,0,0900006480481b0e
FDA-2003-E-0062-0002,FDA,FDA-2003-E-0062,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2004-07-27T04:00:00Z,2004,7,,,2025-10-29T19:23:32Z,,0,0,0900006480481b0c
FDA-2003-E-0062-0001,FDA,FDA-2003-E-0062,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2003-09-04T04:00:00Z,2003,9,,,2025-10-29T19:20:17Z,,0,0,0900006480481afb